Clinical trial
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial…
NCT00113191 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00113191 |
|---|---|
| Title | Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants |
| Official title | A Phase III, Randomized, Double-blind, Multi-center Clinical Trial Comparing the Safety and Efficacy of Veronate® Versus Placebo for the Prevention of Nosocomial Staphylococcal Sepsis in Premature Infants (Birth Weight 500 - 1250 g) |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Nosocomial Infections, Sepsis, Staphylococcal Infections, Candidemia |
| Intervention type | Drug |
| Interventions | Veronate |
| Enrollment | 2,000 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jun 7, 2005 |
| Last update posted | Aug 2, 2012 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: